Morning Dose: Turbo Tuesday Futures Flat, Novo Nordisk Soars
A quick analysis of today’s market outlook and key trading opportunities to start your day.
Intro & Market Mood
Welcome to The Morning Dose – Everything You Need to Know Before the Market Opens! It is Tuesday, December 23rd, 2025. We are staring down the barrel of a holiday week, and the futures look… well, let’s call it ‘muted’ for now.
Overnight Headlines
The S&P 500 is pointing to a flat open, taking a breather after three winning sessions. Watch out for key data releases at 8:30 a.m. Eastern including the first estimate for Q3 GDP, Durable Goods Orders, and Consumer Confidence.
Economic Announcements
- GDP: First estimate for Q3 coming in around 3.0%.
- Durable Goods Orders
- Consumer Confidence
Earnings Highlights
- Novo Nordisk (NVO): Gapping up nearly seven percent after FDA approval for Wegovy.
- ZIM Integrated Shipping: Up 9.5% after strategic review update.
- Beyond Meat: Down almost three percent.
- Neurocrine Biosciences: Taking a hit after missing Phase 3 study endpoints.
Top Movers
Novo Nordisk (NVO) soaring post FDA approval, while ZIM Integrated Shipping sees gains. Beyond Meat and Neurocrine Biosciences face losses.
Quick Trade Ideas
For SPY and QQQ traders, watch support and resistance levels at 684, 686.50, and 618.50. Keep an eye on sector rotation, particularly Staples (XLP) for defensive moves.
Key Takeaway
Amid holiday slowdown, focus on key data releases and technical levels to navigate market indecision. Stay cautious and monitor your positions closely.